Aspire-Lakewood Holdings, Inc. (ASBP) vs Passage Bio, Inc. (PASG)

Aspire-Lakewood Holdings, Inc. and Passage Bio, Inc. are both Biotechnology companies. Aspire-Lakewood Holdings, Inc. and Passage Bio, Inc. are of similar size ($12.1M and $11.6M). Passage Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire-Lakewood Holdings, Inc. trades at 0.2×. Passage Bio, Inc. has the higher net margin (0.00% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Passage Bio, Inc. leads on 7 and Aspire-Lakewood Holdings, Inc. on 5.

Valuation

Metric ASBP PASG Biotechnology median
P/E 0.24 n/m 8.50
P/S 93.27 n/m 9.71
P/B 0.78 2.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.34 0.64
EV/Sales (2.70) n/m 9.21
Earnings yield 413.99% (325.29%) (33.15%)
Free cash flow yield (78.86%) (326.67%) (25.50%)

Profitability

Metric ASBP PASG Biotechnology median
Gross margin (24.97%) 0.00% 65.16%
Operating margin (7,491.61%) 0.00% 0.00%
Net margin (11,309.31%) 0.00% 0.00%
Free cash flow margin (7,355.07%) 0.00% 0.00%
Return on equity (1,032.15%) (169.09%) (56.36%)
Return on assets (152.09%) (69.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASBP PASG Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (762.74%) 32.94% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ASBP PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 1.22 4.72
Net debt to EBITDA (0.16) 0.96 0.96

Dividend

Metric ASBP PASG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ASBP PASG Biotechnology median
Market cap 12.11m 11.59m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack